YOLFTbeta
00

Guangdong Zhongsheng Pharmaceutical Co Ltd

002317 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

25.67CNY-0.05 (-0.19%)

Price History

Full chart

Market Stats

Previous Close25.72
Open25.62
Day Range25.47 – 26.39
52-Week Range16.06 – 34.27
Volume22.07M
Market Cap20.42B
P/E (TTM)100.13
Forward P/E33.00
EPS0.24
Dividend Yield0.83%
Beta0.59
50-Day Avg25.98
200-Day Avg22.21

About

Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers onradir, Leretevir, compound danshen, Cefixime Dispersible, Pyrazinamide, Ethamibutanol Hydrochloride, Ribavirin, loratadine, and isoniazid tablets; compound thromboplastin series, Zhong Sheng Wan series, and heat-clearing and dampness-removing granules products; NaoShuanTong, Cefadroxil, Rifampicin, and omeprazole enteric-coated capsules; carbocysteine, Ambroxol Hydrochloride, and Clomastine fumarate oral solutions; sucralfate oral suspension; reba pat film; and Azalastine Hydrochloride, Praprofen, Diquafosol Sodium, and Cyclosporine eye drops. It also focuses on the fields of respiratory antiviral, ophthalmology, cardiovascular and cerebrovascular endocrinology, anti-infection, digestion, and anti-allergy. Guangdong Zhongsheng Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Dongguan, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Yong Hong Chen
  • Employees1.76K
  • HeadquartersInformation Industry Park, Dongguan, China, 523325, China
  • Websitehttps://www.zspcl.com

Leadership

  • Mr. Yong Hong ChenChairman & President · b. 1971
  • Ms. Yuchong ZhangVice Chairman & Senior VP · b. 1989
  • Ms. Chun Hua LongVP, CFO, Financial Director & Director · b. 1973
  • Mr. Wei YangBoard Secretary · b. 1988
  • Mr. Rikang LuoVice President · b. 1975
  • Mr. Shuang LiuVice President · b. 1977

Financials

Income Statement

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue326.90M404.40M484.31M551.60M640.71M750.64M886.43M1.09B1.31B1.58B1.69B1.96B2.36B2.53B1.90B2.43B2.68B2.61B2.47B2.52B
Growth (%)-+23.71%+19.76%+13.90%+16.16%+17.16%+18.09%+22.97%+20.04%+20.57%+7.27%+16.06%+20.23%+7.20%-25.11%+28.13%+10.17%-2.45%-5.48%+2.24%
Cost of Revenue189.97M214.68M227.07M211.68M234.75M274.98M338.10M451.52M519.61M571.90M515.71M811.28M907.03M917.97M658.79M813.75M941.57M1.08B1.14B1.11B
Gross Profit136.92M189.73M257.24M339.92M405.96M466.99M548.34M638.51M788.90M1.01B1.18B1.15B1.45B1.61B1.24B1.62B1.73B1.53B1.33B1.42B
Gross Margin41.89%46.92%53.11%61.62%63.36%62.21%61.86%58.58%60.29%63.75%69.53%58.70%61.59%63.74%65.25%66.50%64.82%58.58%53.98%56.12%
Operating Expense100.52M133.08M176.92M227.29M280.36M316.89M375.32M458.74M548.10M673.11M714.19M659.26M953.53M1.23B1.56B1.30B1.36B1.23B1.61B1.10B
Operating Income36.40M56.65M80.32M112.63M125.60M150.10M173.02M179.77M240.80M332.72M462.59M493.70M500.95M380.61M-324.19M312.66M374.26M298.73M-279.95M320.61M
Operating Margin11.14%14.01%16.58%20.42%19.60%20.00%19.52%16.49%18.40%21.09%27.33%25.13%21.21%15.03%-17.10%12.87%13.99%11.44%-11.35%12.71%
EBITDA50.01M67.55M104.87M126.34M169.16M195.36M198.92M210.08M265.80M382.82M491.46M464.64M576.35M572.28M352.45M462.45M477.90M465.05M322.53M426.41M
EBITDA Margin15.30%16.70%21.65%22.90%26.40%26.03%22.44%19.27%20.31%24.26%29.04%23.65%24.41%22.61%18.59%19.04%17.86%17.81%13.07%16.90%
Net Income31.88M42.27M74.38M100.35M131.51M150.54M181.51M187.70M224.56M296.71M414.37M420.12M435.65M317.73M-426.61M277.63M322.05M263.27M-299.16M275.75M
Net Income Margin9.75%10.45%15.36%18.19%20.53%20.05%20.48%17.22%17.16%18.81%24.48%21.39%18.45%12.55%-22.50%11.43%12.03%10.08%-12.12%10.93%
R&D5.33M8.34M11.75M-27.57M31.93M31.10M55.74M67.14M67.60M75.04M67.93M84.29M132.58M113.62M136.73M156.59M127.37M116.82M91.03M
R&D as % of Total Revenue1.63%2.06%2.43%-4.30%4.25%3.51%5.11%5.13%4.28%4.43%3.46%3.57%5.24%5.99%5.63%5.85%4.88%4.73%3.61%
Interest Expense3.28M4.73M6.81M3.96M690.30K427.46K433.21K657.82K4.76M9.35M6.33M7.94M34.55M48.22M37.47M73.81M74.20M47.40M26.19M5.00M
Interest Expense % of Total Revenue1.00%1.17%1.41%0.72%0.11%0.06%0.05%0.06%0.36%0.59%0.37%0.40%1.46%1.90%1.98%3.04%2.77%1.82%1.06%0.20%

Balance Sheet

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets291.65M297.74M314.92M1.40B1.48B1.57B1.74B1.99B2.31B3.33B4.23B4.86B5.24B5.51B4.78B4.90B5.78B6.46B5.55B5.13B
Total Liabilities152.93M167.17M142.53M108.46M95.53M92.54M150.41M248.07M407.63M1.22B801.23M1.13B1.29B1.37B1.16B1.36B1.96B1.93B1.54B979.71M
Total Equity128.90M119.01M172.40M1.30B1.39B1.48B1.59B1.68B1.85B2.06B3.39B3.71B3.90B4.07B3.52B3.48B3.70B4.36B3.91B4.06B
Cash49.69M45.18M49.63M1.11B1.05B895.15M906.98M332.64M241.05M140.59M294.49M926.50M928.86M819.88M1.32B1.02B927.67M1.25B1.40B985.40M
Total Debt65.00M90.00M86.52M40.00M---32.50M56.50M172.78M72.64M437.96M814.27M784.26M712.98M503.27M877.62M719.79M303.77M-
Net Debt15.31M44.82M36.88M-1.07B-1.05B-895.15M-906.98M-300.14M-184.55M32.19M-221.85M-488.54M-114.59M-35.62M-610.66M-513.10M-50.05M-532.25M-1.10B-

Cash Flow

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow17.91M49.35M72.86M100.89M91.72M70.56M142.38M110.95M100.60M192.25M338.28M369.91M326.78M251.16M138.93M622.77M63.07M190.61M337.84M305.20M
Investing Cash Flow7.85M-45.25M-37.67M-25.27M-66.75M-185.40M-80.29M-607.34M-225.11M-201.47M-994.24M93.52M-450.78M-240.85M203.78M-684.83M-526.73M-743.24M384.67M-
Financing Cash Flow-19.09M-8.62M-30.73M983.64M-80.23M-43.64M-50.27M-83.24M33.96M-89.62M812.09M165.68M129.29M-118.06M159.39M-244.36M357.60M841.72M-562.17M-
Capital Expenditure9.84M25.67M19.49M22.83M67.02M185.41M77.42M111.91M199.54M76.57M141.19M124.28M143.48M128.33M154.43M213.76M267.96M363.06M228.26M316.17M
Free Cash Flow8.07M23.69M53.37M78.06M24.70M-114.85M64.96M-962.04K-98.95M115.68M197.10M245.62M183.31M122.83M-15.50M409.00M-204.89M-172.44M109.58M-10.97M
Dividends Paid32.94M34.52M27.18M27.80M40.23M60.00M72.00M90.17M93.80M221.34M101.92M160.88M177.80M160.67M160.67M160.14M161.78M171.53M170.95M170.31M
FCF to OCF45.06%48.00%73.25%77.37%26.93%-162.78%45.62%-0.87%-98.36%60.17%58.26%66.40%56.09%48.90%-11.16%65.68%-324.87%-90.47%32.44%-3.59%
Dividend Paid to FCF408.18%145.72%50.93%35.62%162.89%-52.24%110.84%-9372.57%-94.80%191.34%51.71%65.50%97.00%130.81%-1036.45%39.15%-78.96%-99.47%156.01%-1553.03%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Feb 27, 2013Apr 24, 2013Aug 5, 2013Oct 28, 2013Feb 26, 2014Apr 25, 2014Aug 4, 2014Oct 27, 2014Feb 11, 2015Apr 20, 2015Aug 3, 2015Oct 26, 2015Feb 18, 2016Apr 19, 2016Aug 2, 2016Oct 26, 2016Feb 22, 2017Apr 24, 2017Aug 21, 2017Oct 25, 2017Feb 26, 2018Apr 24, 2018Aug 2, 2018Oct 24, 2018Feb 25, 2019Apr 22, 2019Aug 2, 2019Oct 22, 2019Apr 28, 2020Aug 24, 2020Oct 27, 2020Apr 26, 2021Aug 27, 2021Oct 27, 2021Apr 25, 2022Aug 8, 2022Oct 28, 2022Apr 10, 2023Aug 21, 2023Oct 30, 2023Dec 31, 2023Apr 22, 2024Aug 29, 2024Oct 29, 2024Apr 25, 2025Aug 29, 2025Oct 31, 2025Apr 30, 2026Aug 25, 2026
EPS Estimate------------0.070.090.09-0.070.080.080.080.100.130.110.130.110.130.130.110.110.190.110.140.110.200.060.140.080.22-------------0.060.170.14------
EPS Actual0.030.060.050.050.040.060.050.050.050.070.070.070.060.070.060.070.060.090.070.080.090.120.090.100.120.180.100.140.130.170.080.130.150.180.080.110.100.220.08-0.060.160.140.070.290.03-0.050.160.060.090.080.09-0.020.060.040.08-0.530.120.070.120.01
Surprise-------------14.29%-22.22%-33.33%--14.29%12.50%-12.50%0.00%-10.00%-7.69%-18.18%-23.08%9.09%38.46%-23.08%27.27%18.18%-10.53%-27.27%-7.14%36.36%-10.00%33.33%-21.43%25.00%0.00%--------------133.33%-64.71%-71.43%------
Timing------------After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-market-After-hoursAfter-hours-After-hours----

Key Statistics & Ratios

Market Cap20.42B
Enterprise Value20.11B
Trailing P/E100.13
Forward P/E33.00
PEG Ratio0.00
Price / Sales9.19
Price / Book5.29
EPS0.24
Book Value4.71
Revenue (TTM)2.22B
Gross Profit (TTM)1.22B
EBITDA317.65M
Profit Margin8.96%
Operating Margin2.24%
Return on Equity4.64%
Return on Assets2.45%
Shares Outstanding849.93M
Shares Float615.43M
Beta0.59
Dividend Yield0.83%
Dividend Rate0.20
Payout Ratio97.66%

Dividends

20261×
0.20May 29, 2026
20251×
0.20May 29, 2025
20241×
0.20May 23, 2024
20231×
0.20May 16, 2023
20221×
0.20May 27, 2022
20211×
0.20May 28, 2021
20201×
0.20May 29, 2020
20191×
0.20May 23, 2019
20181×
0.18May 24, 2018
20171×
0.18Jun 5, 2017
20161×
0.14May 19, 2016
20152×
0.10Sep 1, 20150.13Apr 16, 2015
20141×
0.25May 27, 2014
20131×
0.13Mar 11, 2013
20121×
0.10May 9, 2012
20111×
0.08May 13, 2011
20101×
0.04May 13, 2010

Stock Splits

  • Sep 1, 201520:10
  • Mar 11, 201320:10
  • May 13, 201115:10
  • May 13, 20101.5:1